LEXARIA BIOSCIENCE CORP. Increase (Decrease) in Due to Related Parties
LEXARIA BIOSCIENCE CORP. (LEXX) reported Increase (Decrease) in Due to Related Parties of $0 for the 12-month period ending 2023-08-31, per its 10-K filed 2023-11-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2023-11-20
- LEXARIA BIOSCIENCE CORP. increase (decrease) in due to related parties for the quarter ending 2023-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in due to related parties for the quarter ending 2023-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in due to related parties for the quarter ending 2023-02-28 was $0.00.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in due to related parties for the quarter ending 2022-11-30 was $0.00.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in due to related parties for fiscal 2023 was $0.00.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in due to related parties for fiscal 2022 was -$5.22K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in due to related parties for fiscal 2021 was -$53.48K, a 604.16% decline from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in due to related parties for fiscal 2020 was $10.61K, a 73.64% decline from fiscal 2019.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|---|
| 2023-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $0.00 derived: sum of 3 quarters · filed 2023-11-20 | $0.00 10-K · filed 2023-11-20 |
| 2023-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | $0.00 derived: sum of 2 quarters · filed 2023-07-14 | $0.00 10-Q · filed 2023-07-14 | $0.00 derived: sum of 4 quarters · filed 2023-11-20 |
| 2023-02-28 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-04-14 | $0.00 10-Q · filed 2023-04-14 | $0.00 derived: sum of 3 quarters · filed 2023-11-20 | $0.00 derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-11-30 | $0.00 10-Q/A · filed 2023-01-18 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $0.00 derived: sum of 3 quarters · filed 2023-11-20 | $0.00 derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $0.00 derived: sum of 3 quarters · filed 2023-11-20 | -$5.22K 10-K · filed 2023-11-20 |
| 2022-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | $0.00 derived: sum of 2 quarters · filed 2023-07-14 | -$5.22K 10-Q · filed 2023-07-14 | -$1.32K derived: sum of 4 quarters · filed 2023-07-14 |
| 2022-02-28 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-04-14 | -$5.22K 10-Q · filed 2023-04-14 | -$1.32K derived: sum of 3 quarters · filed 2023-04-14 | -$206.81K derived: sum of 4 quarters · filed 2023-04-14 |
| 2021-11-30 | -$5.22K 10-Q/A · filed 2023-01-18 | -$1.32K derived: sum of 2 quarters · filed 2023-01-18 | -$206.81K derived: sum of 3 quarters · filed 2023-01-18 | -$87.19K derived: sum of 4 quarters · filed 2023-01-18 |
| 2021-08-31 | $3.90K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | -$201.58K derived: sum of 2 quarters · filed 2022-11-28 | -$81.96K derived: sum of 3 quarters · filed 2022-11-28 | -$53.48K 10-K · filed 2022-11-28 |
| 2021-05-31 | -$205.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | -$85.86K derived: sum of 2 quarters · filed 2022-07-14 | -$57.38K 10-Q · filed 2022-07-14 | -$28.27K derived: sum of 4 quarters · filed 2022-07-14 |
| 2021-02-28 | $119.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11 | $148.10K 10-Q · filed 2022-04-11 | $177.21K derived: sum of 3 quarters · filed 2022-04-11 | $205.21K derived: sum of 4 quarters · filed 2022-04-11 |
| 2020-11-30 | $28.48K 10-Q · filed 2022-01-14 | $57.59K derived: sum of 2 quarters · filed 2022-01-14 | $85.58K derived: sum of 3 quarters · filed 2022-01-14 | $49.98K derived: sum of 4 quarters · filed 2022-01-14 |
| 2020-08-31 | $29.11K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $57.10K derived: sum of 2 quarters · filed 2021-11-29 | $21.50K derived: sum of 3 quarters · filed 2021-11-29 | $10.61K 10-K · filed 2021-11-29 |
| 2020-05-31 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | -$7.61K derived: sum of 2 quarters · filed 2021-04-14 | -$18.50K 10-Q · filed 2020-06-29 | $8.60K derived: sum of 4 quarters · filed 2021-04-14 |
| 2020-02-29 | -$35.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | -$46.50K 10-Q · filed 2021-04-14 | -$19.39K derived: sum of 3 quarters · filed 2021-04-14 | -$4.02K derived: sum of 4 quarters · filed 2021-04-14 |
| 2019-11-30 | -$10.90K 10-Q · filed 2021-01-14 | $16.20K derived: sum of 2 quarters · filed 2021-01-14 | $31.58K derived: sum of 3 quarters · filed 2021-01-14 | $15.55K derived: sum of 4 quarters · filed 2021-01-14 |
| 2019-08-31 | $27.10K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $42.48K derived: sum of 2 quarters · filed 2020-10-15 | $26.44K derived: sum of 3 quarters · filed 2020-10-15 | $40.24K 10-K · filed 2020-10-15 |
| 2019-05-31 | $15.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | -$659.00 derived: sum of 2 quarters · filed 2020-06-29 | $13.14K 10-Q · filed 2020-06-29 | $11.88K derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-02-28 | -$16.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | -$2.23K 10-Q · filed 2020-04-03 | -$3.49K derived: sum of 3 quarters · filed 2020-04-03 | $27.00 derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-11-30 | $13.80K 10-Q · filed 2020-01-09 | $12.54K derived: sum of 2 quarters · filed 2020-01-09 | $16.06K derived: sum of 3 quarters · filed 2020-01-09 | -$3.36K derived: sum of 4 quarters · filed 2020-01-09 |
| 2018-08-31 | -$1.25K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $2.26K derived: sum of 2 quarters · filed 2019-11-14 | -$17.16K derived: sum of 3 quarters · filed 2019-11-14 | -$34.84K 10-K · filed 2019-11-14 |
| 2018-05-31 | $3.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | -$15.91K derived: sum of 2 quarters · filed 2019-07-08 | -$33.58K 10-Q · filed 2019-07-08 | $1.66K derived: sum of 4 quarters · filed 2019-07-08 |
| 2018-02-28 | -$19.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | -$37.10K 10-Q · filed 2019-04-15 | -$1.85K derived: sum of 3 quarters · filed 2019-04-15 | -$245.02K derived: sum of 4 quarters · filed 2019-04-15 |
| 2017-11-30 | -$17.67K 10-Q · filed 2019-01-11 | $17.57K derived: sum of 2 quarters · filed 2019-01-11 | -$225.60K derived: sum of 3 quarters · filed 2019-01-11 | -$302.97K derived: sum of 4 quarters · filed 2019-01-11 |
| 2017-08-31 | $35.24K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | -$207.93K derived: sum of 2 quarters · filed 2018-11-14 | -$285.30K derived: sum of 3 quarters · filed 2018-11-14 | -$238.68K 10-K · filed 2018-11-14 |
| 2017-05-31 | -$243.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | -$320.55K derived: sum of 2 quarters · filed 2018-07-13 | -$273.93K 10-Q · filed 2018-07-13 | -$23.43K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-02-28 | -$77.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | -$30.76K 10-Q · filed 2018-04-12 | $219.74K derived: sum of 3 quarters · filed 2018-11-14 | |
| 2016-11-30 | $46.62K 10-Q · filed 2018-01-12 | $297.12K derived: sum of 2 quarters · filed 2018-11-14 | ||
| 2016-08-31 | $250.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $259.32K 10-K · filed 2018-11-14 | ||
| 2016-05-31 | $8.82K 10-Q · filed 2017-07-14 | |||
| 2016-02-29 | $0.00 10-Q · filed 2017-04-14 | |||
| 2015-11-30 | $92.69K 10-Q · filed 2017-01-13 | |||
| 2015-08-31 | $20.28K 10-K · filed 2016-11-29 | |||
| 2014-08-31 | $0.00 10-K · filed 2015-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |